Recommendations for Follow-Up after Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

Samir Gupta; David Lieberman; Joseph C. Anderson; Carol A. Burke; Jason A. Dominitz; Tonya Kaltenbach; Douglas J. Robertson; Aasma Shaukat; Sapna Syngal; Douglas K. Rex

doi:10.14309/ajg.0000000000000544

Recommendations for Follow-Up after Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

Samir Gupta, David Lieberman, Joseph C. Anderson, Carol A. Burke, Jason A. Dominitz, Tonya Kaltenbach, Douglas J. Robertson, Aasma Shaukat, Sapna Syngal, Douglas K. Rex

Gastroenterology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	415-434
Number of pages	20
Journal	American Journal of Gastroenterology
Volume	115
Issue number	3
DOIs	https://doi.org/10.14309/ajg.0000000000000544
State	Published - Mar 1 2020

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.14309/ajg.0000000000000544

Cite this

Gupta, S., Lieberman, D., Anderson, J. C., Burke, C. A., Dominitz, J. A., Kaltenbach, T., Robertson, D. J., Shaukat, A., Syngal, S., & Rex, D. K. (2020). Recommendations for Follow-Up after Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. American Journal of Gastroenterology, 115(3), 415-434. https://doi.org/10.14309/ajg.0000000000000544

Recommendations for Follow-Up after Colonoscopy and Polypectomy : A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. / Gupta, Samir; Lieberman, David; Anderson, Joseph C.; Burke, Carol A.; Dominitz, Jason A.; Kaltenbach, Tonya; Robertson, Douglas J.; Shaukat, Aasma; Syngal, Sapna; Rex, Douglas K.

In: American Journal of Gastroenterology, Vol. 115, No. 3, 01.03.2020, p. 415-434.

Research output: Contribution to journal › Article › peer-review

Gupta, S, Lieberman, D, Anderson, JC, Burke, CA, Dominitz, JA, Kaltenbach, T, Robertson, DJ, Shaukat, A, Syngal, S & Rex, DK 2020, 'Recommendations for Follow-Up after Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer', American Journal of Gastroenterology, vol. 115, no. 3, pp. 415-434. https://doi.org/10.14309/ajg.0000000000000544

Gupta, Samir ; Lieberman, David ; Anderson, Joseph C. ; Burke, Carol A. ; Dominitz, Jason A. ; Kaltenbach, Tonya ; Robertson, Douglas J. ; Shaukat, Aasma ; Syngal, Sapna ; Rex, Douglas K. / Recommendations for Follow-Up after Colonoscopy and Polypectomy : A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. In: American Journal of Gastroenterology. 2020 ; Vol. 115, No. 3. pp. 415-434.

@article{a55f8f545d0841dfabb524fa3cd81c5e,

title = "Recommendations for Follow-Up after Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer",

author = "Samir Gupta and David Lieberman and Anderson, {Joseph C.} and Burke, {Carol A.} and Dominitz, {Jason A.} and Tonya Kaltenbach and Robertson, {Douglas J.} and Aasma Shaukat and Sapna Syngal and Rex, {Douglas K.}",

note = "Funding Information: Conflicts of interest The authors disclose no conflicts of interest relative to the current work since 2016. Industry relationships for authors (consulting, research, reimbursement) without conflicts of interest relevant to the current work since 2016: Douglas K. Rex (Olympus, Boston Scientific, Covidien, Lumendi, Salix, Aries, Cook Medical, ERBE, Bausch Health Inc, Novo Nordisk, Endochoice, Braintree Laboratories, Norgine, Endokey, EndoAid, Medivators, Satisfai Health); Sapna Syngal (Chirhoclin, Cook, Myriad Genetics, Inc, DC Health, Inc); David Lieberman (Covidien, Freenome Holdings, Inc, Ironwood, Check-Cap, CEGX); Douglas Robertson (Covidien, Freenome Holdings, Inc, Amadix); Tonya Kaltenbach (Aries Pharmaceuticals, Micro-Tech Endoscopy, Olympus, Boston Scientific, Medtronic); Aasma Shaukat (None); Samir Gupta (Freenome Holdings, Inc, Guardant Health, Inc, Mallinckrodt Pharmaceuticals); Carol Burke (Salix Pharmaceuticals, Ferring Pharmaceuticals, Aries Pharmaceuticals, Intuitive Surgical, Pfizer, Covidien, Boston Scientific, US Endoscopy, Abbvie Cancer Prevention Pharmaceuticals, Janssen Pharmaceuticals; SLA Pharma AG; Freenome Holdings, Inc). Jason Dominitz (None); Joseph C. Anderson (None). Funding This work was supported in part by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Number R37 CA222866 and the Department of Veterans Affairs under Award Number I01 HX001574, as well as NIH awards P30CA06516 and UO1 CA864000.",

year = "2020",

month = mar,

day = "1",

doi = "10.14309/ajg.0000000000000544",

language = "English (US)",

volume = "115",

pages = "415--434",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Recommendations for Follow-Up after Colonoscopy and Polypectomy

T2 - A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

AU - Gupta, Samir

AU - Lieberman, David

AU - Anderson, Joseph C.

AU - Burke, Carol A.

AU - Dominitz, Jason A.

AU - Kaltenbach, Tonya

AU - Robertson, Douglas J.

AU - Shaukat, Aasma

AU - Syngal, Sapna

AU - Rex, Douglas K.

N1 - Funding Information: Conflicts of interest The authors disclose no conflicts of interest relative to the current work since 2016. Industry relationships for authors (consulting, research, reimbursement) without conflicts of interest relevant to the current work since 2016: Douglas K. Rex (Olympus, Boston Scientific, Covidien, Lumendi, Salix, Aries, Cook Medical, ERBE, Bausch Health Inc, Novo Nordisk, Endochoice, Braintree Laboratories, Norgine, Endokey, EndoAid, Medivators, Satisfai Health); Sapna Syngal (Chirhoclin, Cook, Myriad Genetics, Inc, DC Health, Inc); David Lieberman (Covidien, Freenome Holdings, Inc, Ironwood, Check-Cap, CEGX); Douglas Robertson (Covidien, Freenome Holdings, Inc, Amadix); Tonya Kaltenbach (Aries Pharmaceuticals, Micro-Tech Endoscopy, Olympus, Boston Scientific, Medtronic); Aasma Shaukat (None); Samir Gupta (Freenome Holdings, Inc, Guardant Health, Inc, Mallinckrodt Pharmaceuticals); Carol Burke (Salix Pharmaceuticals, Ferring Pharmaceuticals, Aries Pharmaceuticals, Intuitive Surgical, Pfizer, Covidien, Boston Scientific, US Endoscopy, Abbvie Cancer Prevention Pharmaceuticals, Janssen Pharmaceuticals; SLA Pharma AG; Freenome Holdings, Inc). Jason Dominitz (None); Joseph C. Anderson (None). Funding This work was supported in part by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Number R37 CA222866 and the Department of Veterans Affairs under Award Number I01 HX001574, as well as NIH awards P30CA06516 and UO1 CA864000.

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85081944354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081944354&partnerID=8YFLogxK

U2 - 10.14309/ajg.0000000000000544

DO - 10.14309/ajg.0000000000000544

M3 - Article

C2 - 32039982

AN - SCOPUS:85081944354

VL - 115

SP - 415

EP - 434

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 3

ER -